key: cord-0831318-5zp3p2g3
authors: Moghadas, Seyed M.; Fitzpatrick, Meagan C.; Shoukat, Affan; Zhang, Kevin; Galvani, Alison P.
title: Simulated Identification of Silent COVID-19 Infections Among Children and Estimated Future Infection Rates With Vaccination
date: 2021-04-23
journal: JAMA Netw Open
DOI: 10.1001/jamanetworkopen.2021.7097
sha: d33fa9fe4fa37f60ad037ce1a24f7fb095fd97b4
doc_id: 831318
cord_uid: 5zp3p2g3

IMPORTANCE: A significant proportion of COVID-19 transmission occurs silently during the presymptomatic and asymptomatic stages of infection. Children, although important drivers of silent transmission, are not included in the current COVID-19 vaccination campaigns. OBJECTIVE: To estimate the benefits of identifying silent infections among children as a proxy for their vaccination. DESIGN, SETTING, AND PARTICIPANTS: This study used an age-structured disease transmission model, parameterized with census data and estimates from published literature, to simulate the estimated synergistic effect of interventions in reducing attack rates during the course of 1 year among a synthetic population representative of the US demographic composition. The population included 6 age groups of 0 to 4, 5 to 10, 11 to 18, 19 to 49, 50 to 64, and 65 years or older based on US census data. Data were analyzed from December 12, 2020, to February 26, 2021. EXPOSURES: In addition to the isolation of symptomatic cases within 24 hours of symptom onset, vaccination of adults was implemented to reach a 40% to 60% coverage during 1 year with an efficacy of 95% against symptomatic and severe COVID-19. MAIN OUTCOMES AND MEASURES: The combinations of proportion and speed for detecting silent infections among children that would suppress future attack rates to less than 5%. RESULTS: In the base-case scenarios with an effective reproduction number R(e) = 1.2, a targeted approach that identifies 11% of silent infections among children within 2 days and 14% within 3 days after infection would bring attack rates to less than 5% with 40% vaccination coverage of adults. If silent infections among children remained undetected, achieving the same attack rates would require an unrealistically high vaccination coverage (≥81%) of this age group, in addition to 40% vaccination coverage of adults. The estimated effect of identifying silent infections was robust in sensitivity analyses with respect to vaccine efficacy against infection and reduced susceptibility of children to infection. CONCLUSIONS AND RELEVANCE: In this simulation modeling study of a synthetic US population, in the absence of vaccine availability for children, a targeted approach to rapidly identify silent COVID-19 infections in this age group was estimated to significantly mitigate disease burden. These findings suggest that without measures to interrupt transmission chains from silent infections, vaccination of adults is unlikely to contain the outbreaks in the near term.

We modelled the transmission of SARS-CoV-2 by extending an age-structured SEIR (Susceptible, Exposed, Infectious, Recovered) to include additional compartments of asymptomatic, pre-symptomatic, symptomatic, and isolation of infected individuals (eFigure 1). We further included compartments to describe vaccination dynamics. The total population was divided into five age groups as specified in the main text. We omitted the demographic variables of births and deaths. With the variables described in eTable 1, the model is expressed by the following system of equations: In this model, is the transmission parameter (calibrated to an effective reproduction number . The reproduction number denotes the average number of secondary infections caused by an infected individual before recovering and becoming immune (or dying) in the presence of measures that aim to control disease spread. We calibrated the transmission parameter by calculating the spectral radius of the next-generation matrix [1] . A full description of all model parameters is given in eTable 2. The population was stratified into six age groups: 0-4, 5-10, 11-18, 19-49, 50-64, 65+. Transmission between and within age groups was based on heterogeneous mixing with rates determined by age-specific contact matrices [2, 3] where in each matrix, the elements { ij | , ∈ (1, ⋯ ,6)} denote the average contact rates between age groups and .

In our model, all newly infected individuals start in the latent stage for an average period of 1/σ days. After this period has elapsed, infected individuals move to a communicable silent infection stage (i.e., asymptomatic or pre-symptomatic). Unlike asymptomatic cases, those who enter pre-symptomatic stage will develop symptoms. We assumed that all symptomatic cases initiate self-isolation within 24 hours of their symptom onset. The average infectious periods in different stages of the disease and their associated distributions are summarized in eTable 2. Recovery from infection was assumed to provide immunity against re-infection during the simulations.

To include vaccination dynamics, we considered age-dependent vaccination rates to achieve a 40% vaccine coverage in adults within 1 year, with a distribution of 80% for age groups 50+ and 22% for individuals aged 19-49. Vaccination was assumed to prevent infection with an efficacy that is 50% lower than its efficacy against symptomatic disease (and 95% in additional scenarios presented in as sensitivity analysis in this appendix). If infection occurred postvaccination, we assumed the probability of developing symptomatic disease is reduced by a factor a corresponding to the vaccine efficacy of 95% [13] .

For simulating the model, we used a non-standard numerical method to discretize the system and ran the simulations (in MATLAB©) with introducing one latent individual into each age group in the model. 

Evidence is accumulating that young children may have a reduced susceptibility to SARS-CoV-2, with stronger immune responses that may prevent the development of symptomatic or severe disease [14, 15] . We therefore simulated the model by considering a 50% reduction of susceptibility for children under 10 years of age. Qualitatively, the effect of identifying silent infections on the reduction of attack rates remains intact and the speed of identification is critical for outbreak control. Projected attack rates for the range of 2-5 days delay in identification of silent infections among children, when only adults are vaccinated, are presented in eFigure 2.

We also simulated the model to determine the effect of vaccine coverage on the minimum level of silent infections required to be identified among children in order to bring the overall attack rate in the population below 5% (eFigure 3). 

In the absence of data on vaccine efficacy against infection, we further simulated the model with the same efficacy of 95% against symptomatic disease, while also considering 50% reduced susceptibility for children under 10 years old. The results presented in eFigure 4 below illustrate a qualitative similar pattern to those presented in Figure 2 of the main text, indicating that the sharpest decline of attack rates occur with rapid identification of 0% -15% silent infections among children within 2-3 days post-infection. = .

Depending on various factors (e.g., the characteristics of the disease, interventions, and other heterogeneities in the population), the reproduction number of diseases may change. As sensitivity analysis, we simulated the model when the reproduction number was increased to = 1.5. Not surprisingly, attack rates were estimated to be higher and a greater proportion of silent infections in the population (without vaccination) and among children (with vaccination of adults) would need to be identified in order to suppress the overall attack rate below 5%. eFigures 5-7 show the results without vaccination, and when the vaccination coverage of adults is reached 40% over the course of 1-year. These simulations also consider reduced susceptibility of children under 10 years of age in scenarios with varying vaccine efficacy against infection (i.e., the same or 50% lower than the efficacy against symptomatic disease). When the reproduction was below one (simulated with = 0.9), we found that with a 40% vaccine coverage, attack rates remained below 5% irrespective of the proportion of silent infection identified in the population or among children. However, as identification of silent infections increases with shorter delay post-infection, an earlier control of outbreak can be achieved.

On the definition and the computation of the basic reproduction ratio R 0 in models for infectious diseases in heterogeneous populations

Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases

Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK

Infectivity of asymptomatic versus symptomatic COVID-19

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta analysis

The implications of silent transmission for the control of COVID-19 outbreaks

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

Temporal dynamics in viral shedding and transmissibility of COVID-19

Moderna's COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study -Moderna

Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study -Pfizer

Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine

Immune responses to SARS-CoV-2 in three children of parents